Gossamer Bio, Inc.

Good day, ladies and gentlemen.

Your conference call will begin in approximately two minutes. Thank you for your patience. . . . . . . . . . . Thank you for watching. Good morning and welcome to the Gossamer Bio first quarter 2019 earnings call. Today's call will feature updates from Gossamer Bio management's team, followed by a question and answer session. I will now turn the call over to Gossamer's chief financial officer, Bryan Giraudo. Bryan?

Thank you, operator, and thank you all for joining us this morning. With me on today's call is Gossamer's co-founder and chief executive officer, Dr. Sheila Gujarati. Earlier this morning, Gossamer issued a press release announcing its financial results for the first quarter ended March 31, 2019, and provided a corporate update. Please note that certain information discussed on the call today is covered under the safe harbor provision of the Private Securities Litigation Reform Act. We caution listeners that during this call, Gossamer management will be making forward-looking statements. Actual results may differ materially from those stated or implied by these forward-looking statements due to risks and uncertainties associated with the company's business. These forward-looking statements are qualified by the statements contained in Gossamer's news releases, SEC filings, including the annual report on Form 10-K and subsequent filings. This conference call also contains time-sensitive information that may be accurate for only a limited period of time. Gossamer Bio undertakes no obligation to revise or update any forward-looking statements to reflect events or circumstances after the date of this conference call. Now with all of those wonderful remarks, I will turn it over to Sheila. Sheila?